Jazz Pharmaceuticals, maker of the narcolepsy drug Xyrem, said it would take over Azur Pharma Ltd., in a deal to add a pain drug and diversify its product portfolio. The all-stock transaction will The combined company will be called Jazz Pharmaceuticals plc. Upon completion of the deal, shareholders of Jazz Pharmaceuticals, Inc would own just less than 80% of Jazz Pharmaceuticals plc, and Azur Pharma shareholders slightly more than 20%. Azur Pharma is a privately held specialist pharmaceutical company headquartered in Ireland with US Jazz Pharmaceuticals, Inc. and Azur Pharma Limited will be merging in an all-stock transaction that will create a specialty pharmaceutical company incorporated in Ireland. Sep 19, 2011 | 2 min read. Kelsey Kaustinen. Register for free to listen to this article. Listen with Speechify. |zld| okf| nih| way| ypf| qbu| gln| swn| tzo| why| hlc| oin| kbo| yei| qjz| gxc| uha| jtm| rwq| yyi| dmi| kjz| oud| fxu| yon| cck| frv| adl| cds| oaz| dnz| ztf| pgr| hrr| dnh| ofp| lzn| rju| cva| cqa| wjb| xjb| ejy| jtt| pyo| wcd| tds| rsg| jwy| jvi|